This module covers the molecular mechanisms that underlie cancer development, growth and metastasis, and the differences between different cancers. It will explore the different molecular and cellular actions of anti-cancer treatments, the genomic factors affecting response and resistance to treatment, and the research approaches to anti-cancer drug design and development. Broad situations which confer a high cancer risk to a person and/or to other members of the same family will be discussed in the context of how genomic information may be integrated into cancer screening programmes, and the impact this may have on the patient and their family. This module will also prepare students to interrogate the cancer data sets from the 100,000 Genomes Project if relevant for their research project.
15 Masters level credits
Module attendance required
Teaching delivered one day each week for five consecutive weeks.
8/15/22 November and 6/13 December 2019
The module will be assessed via a poster presentation, a 3000-word essay assignment and short-answer/case study problems completed in your own time. For those taking the module as a stand-alone option, you need only take the assessment if you require the University credits.
Academics involved in the delivery of this module
Professor Paul Murray (Professor of Molecular Pathology, University of Birmingham)
Other University staff teaching:
NHS staff teaching:
- Dr Philippe Taniere
- Dr Rachel Brown
- Dr Graham Halford
- Dr Brendan Sullivan
- Dr Ana Bras Goldberg
- Dr Abeer Shaaban
- Dr Matthew Smith
- Dr Zbigniew Rudzki
- Dr Pauline Rehal
- Dr Samantha Butler
This module can be taken as a stand-alone assessed or non-assessed course.
You should have a good honours degree in a life sciences subject, although we will consider applicants with alternative qualifications and professional experience within the health service or other relevant background. You should either take An Introduction to Human Genetics and Genomics and module 2 Omics Techniques and their Application to Genomic Medicine first, or be able to show you have equivalent knowledge and understanding to enable you to benefit from this module.
Please contact the Programme Administrator for further information at email@example.com